Cargando…

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists

SIMPLE SUMMARY: Preferences for treatment strategies for low-risk ductal carcinoma in situ (DCIS), a potential precursor of invasive breast cancer (IBC) including a new active surveillance strategy, were elicited with a discrete choice experiment among recently-diagnosed women and oncologists involv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byng, Danalyn, Retèl, Valesca P., Engelhardt, Ellen G., Groothuis-Oudshoorn, Catharina G. M., van Til, Janine A., Schmitz, Renée S. J. M., van Duijnhoven, Frederieke, Wesseling, Jelle, Bleiker, Eveline, van Harten, Wim H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394332/ https://www.ncbi.nlm.nih.gov/pubmed/34439126 http://dx.doi.org/10.3390/cancers13163962

Ejemplares similares

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
por: Byng, Danalyn, et al.
Publicado: (2021)

Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial
por: Schmitz, Renée S.J.M., et al.
Publicado: (2023)

Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery
por: Lindenberg, Melanie, et al.
Publicado: (2020)

Association between genomic recurrence risk and well-being among breast cancer patients
por: Retèl, Valesca P, et al.
Publicado: (2013)

The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review
por: Alaeikhanehshir, Sena, et al.
Publicado: (2020)

Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review
por: Schmitz, Renée S. J. M., et al.
Publicado: (2022)

Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis
por: van Til, Janine, et al.
Publicado: (2020)

Does technique matter; a pilot study exploring weighting techniques for a multi-criteria decision support framework
por: van Til, Janine, et al.
Publicado: (2014)

Patient and Public Preferences for Treatment Attributes in Parkinson’s Disease
por: Weernink, Marieke G. M., et al.
Publicado: (2017)

Public stated preferences and predicted uptake for genome-based colorectal cancer screening
por: Groothuis-Oudshoorn, Catharina GM, et al.
Publicado: (2014)

A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions
por: Broekhuizen, Henk, et al.
Publicado: (2015)

Primary care in five European countries: A citizens’ perspective on the quality of care for children
por: van Til, Janine A., et al.
Publicado: (2019)

What Does the Public Want? Structural Consideration of Citizen Preferences in Health Care Coverage Decisions
por: Cleemput, Irina, et al.
Publicado: (2018)

The impact of an online patient decision aid for women with breast cancer considering immediate breast reconstruction: study protocol of a multicenter randomized controlled trial
por: ter Stege, Jacqueline A., et al.
Publicado: (2019)

Public Preferences in Priority Setting when Admitting Patients to the ICU During the COVID-19 Crisis: A Pilot Study
por: Gijsbers, Merle, et al.
Publicado: (2021)

Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
por: Schmitz, Renée S J M, et al.
Publicado: (2023)

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer
por: van de Ven, Michiel, et al.
Publicado: (2022)

Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
por: Weernink, Marieke G. M., et al.
Publicado: (2018)

Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease
por: Weernink, Marieke G. M., et al.
Publicado: (2016)

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2020)

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes
por: Lindenberg, Melanie A., et al.
Publicado: (2022)

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2022)

The ICECAP-A instrument for capabilities: assessment of construct validity and test–retest reliability in a general Dutch population
por: Rohrbach, Pieter J., et al.
Publicado: (2021)

Women’s preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment
por: Wong, Xin Yi, et al.
Publicado: (2018)

Scenario drafting to anticipate future developments in technology assessment
por: Retèl, Valesca P, et al.
Publicado: (2012)

Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations
por: Franzen, Nora, et al.
Publicado: (2022)

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients
por: Miquel-Cases, Anna, et al.
Publicado: (2016)

Low-risk DCIS. What is it? Observe or excise?
por: Pinder, Sarah E., et al.
Publicado: (2021)

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis
por: van Amerongen, Rosa A, et al.
Publicado: (2016)

Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation
por: van Harten, WH, et al.
Publicado: (2016)

Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology
por: van Harten, WH, et al.
Publicado: (2016)

A preference-based item response theory model to measure health: concept and mathematics of the multi-attribute preference response model
por: Groothuis-Oudshoorn, Catharina G. M., et al.
Publicado: (2018)

Microcalcification crystallography as a potential marker of DCIS recurrence
por: Gosling, Sarah B., et al.
Publicado: (2023)

Whole genome sequencing in oncology: using scenario drafting to explore future developments
por: van de Ven, Michiel, et al.
Publicado: (2021)

Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product
por: Lindenberg, Melanie A., et al.
Publicado: (2018)

Exploring the importance of controlling heteroskedasticity and heterogeneity in health valuation: a case study on Dutch EQ-5D-5L
por: Karim, Suzana, et al.
Publicado: (2022)

Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022)

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation
por: Verbeek, Joost G. E., et al.
Publicado: (2023)

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy
por: Retèl, Valesca P, et al.
Publicado: (2011)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ho62rg25b3dv0c26kkrt00fgnp